Weight Loss Medication Recall

En español | the recall of a pair of weight loss drugs could have consumers worried about cancer, but experts say those risks appear to be small the food and drug administration (fda) this month requested that the makers of belviq and belviq xr voluntarily withdraw the products from us shelves after finding evidence they raised the risk of lung, colon and pancreatic cancers. Weight loss medication recall. Popular weight loss drug belviq is being recalled after a safety clinical trial showed an “increased occurrence of cancer” following the trial, the us food and drug administration (fda) requested a belviq recall from eisai co, the manufacturer eisai acceded to the fda’s request, though the company claims that their interpretation of the clinical trial is different from the fda’s.

weight loss medication recall

Lasix | bad drug

The us food and drug administration has requested that eisai inc, the manufacturer of the weight loss drug belviq, recall the drug after a study found that it could increase the risk of developing pancreatic cancer, colorectal cancer, or lung cancer the fda has advised patients who are taking belviq or belviq xr to stop using the drug immediately due to concerns that it may cause cancer. The follow-up study was initially requested by the fda to examine the risk of heart problems, a common concern with some weight-loss drugs. it enrolled 12,000 patients and took five years to complete.. Unfortunately, weight loss medications have a long history of exposing users to cardiovascular problems and other serious or potentially life-threatening side effects, and federal regulators have determined that the potential link between belviq and cancer is enough to warrant a belviq recall..

more info weight loss medication recall ---> click here